General details
Tax Identification Number (N.I.F): A-96184882
Company name: Laboratorio Reig Jofre SA
Abbreviated name: Reig Jofre
Sector: Pharma
Legal Entity Identifier (LEI): 9598003MRMJHA81QJF20
Share capital
Number of shares: 76,802,279
Par value: 0.50 euros/share
Ordinary stock: 38,401,139.50 Euros
Number of attributed voting rights: 76,802,279
Number of shares required for each voting right: 1
Stock market trading
Share identification number (ISIN): ES0165359029
Incorporation to the interconnected trading system: 29/11/2002
Markets: Barcelona, Bilbao, Madrid and Valencia
Trading ticker: RJF/AC
Capital nominal R.V.: 128,306,356 Euros
Trading type: Equities only
62.7% – Reig Jofre Investments SL
10.1% – Kaizaharra Corp
5.8% – Onchena, SL
20.7%Free float
0.7% – Treasury Stock

On September 22, 2015 the cancellation and consolidation of shares (reverse split) approved by the Ordinary and Extraordinary General Shareholders’ Meeting of Laboratorio Reig Jofre SA of June 11, 2015 was formalized with an exchange ratio of 20 existing shares for every new share.

Summary of the reverse split:.

Before the reverse split
Shares composing the share capital: 1,264,284,408
Par value: 0.10 euros/share
ISIN number: ES0165359011

After the reverse split
Shares composing the share capital: 63,214,220
Par value: 2.00 euros/share
ISIN number: ES0165359029

On December 31, 2019, the company owned 390,279 own shares, representing 0.3% of the share capital.

Reig Jofre currently holds no shareholding in any listed company.